Trump Announces Weight Loss Drug Price Deals With Eli Lilly and Novo Nordisk
President Trump announced on November 6, 2025, that his administration had reached agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to dramatically reduce prices for popular weight loss and diabetes medications, including Ozempic, Wegovy, Mounjaro, Zepbound, and Orforglipron. …
Donald Trump
Eli Lilly
Novo Nordisk
Department of Health and Human Services
healthcare
pharmaceutical-industry
drug-pricing
medicare
political-messaging
Read more →